Combination Therapy of Hydroxyurea With L-Carnitine and Magnesium Chloride in Thalassemia Intermedia
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is determination of the efficacy of combination of hydroxyurea with
L-carnitine or magnesium in improving hematologic parameters and cardiac status in patients
with β-thalassemia intermedia in comparison with hydroxyurea alone .